158 related articles for article (PubMed ID: 32259320)
1. Ultra-low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma.
Buedts L; Smits S; Ameye G; Lehnert S; Ding J; Delforge M; Vermeesch J; Boeckx N; Tousseyn T; Michaux L; Vandenberghe P; Dewaele B
Genes Chromosomes Cancer; 2020 Aug; 59(8):465-471. PubMed ID: 32259320
[TBL] [Abstract][Full Text] [Related]
2. Ultra-low coverage whole genome sequencing of ccfDNA in multiple myeloma: A tool for laboratory routine?
Rengifo LY; Smits S; Buedts L; Delforge M; Dehaspe L; Tousseyn T; Boeckx N; Lehnert S; Michaux L; Vermeesch JR; Vandenberghe P; Dewaele B
Cancer Treat Res Commun; 2021; 28():100380. PubMed ID: 33962213
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.
Rack K; Vidrequin S; Dargent JL
J Clin Pathol; 2016 Jan; 69(1):82-6. PubMed ID: 26338801
[TBL] [Abstract][Full Text] [Related]
4. Low-depth sequencing for copy number abnormalities in multiple myeloma supersedes fluorescent in situ hybridization in scope and resolution.
Elnenaei MO; Knopf P; Cutler SD; Sinclair K; Abou El Hassan M; Greer W; Goudie M; Wagner J; White D; Couban S; Forward N; Gaston D; Campbell CJV
Clin Genet; 2019 Aug; 96(2):163-168. PubMed ID: 31066036
[TBL] [Abstract][Full Text] [Related]
5. The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?
Höllein A; Twardziok SO; Walter W; Hutter S; Baer C; Hernandez-Sanchez JM; Meggendorfer M; Haferlach T; Kern W; Haferlach C
Cancer Genet; 2020 Apr; 242():15-24. PubMed ID: 31980417
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation.
Hayes JL; Tzika A; Thygesen H; Berri S; Wood HM; Hewitt S; Pendlebury M; Coates A; Willoughby L; Watson CM; Rabbitts P; Roberts P; Taylor GR
Genomics; 2013 Sep; 102(3):174-81. PubMed ID: 23598253
[TBL] [Abstract][Full Text] [Related]
7. An alternative to array-based diagnostics: a prospectively recruited cohort, comparing arrayCGH to next-generation sequencing to evaluate foetal structural abnormalities.
Walker L; Watson CM; Hewitt S; Crinnion LA; Bonthron DT; Cohen KE
J Obstet Gynaecol; 2019 Apr; 39(3):328-334. PubMed ID: 30714504
[TBL] [Abstract][Full Text] [Related]
8. Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.
Seed G; Yuan W; Mateo J; Carreira S; Bertan C; Lambros M; Boysen G; Ferraldeschi R; Miranda S; Figueiredo I; Riisnaes R; Crespo M; Rodrigues DN; Talevich E; Robinson DR; Kunju LP; Wu YM; Lonigro R; Sandhu S; Chinnaiyan AM; de Bono JS
Clin Cancer Res; 2017 Oct; 23(20):6070-6077. PubMed ID: 28751446
[No Abstract] [Full Text] [Related]
9. Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.
Berry NK; Bain NL; Enjeti AK; Rowlings P
J Clin Pathol; 2014 Jan; 67(1):66-9. PubMed ID: 23969274
[TBL] [Abstract][Full Text] [Related]
10. Shallow whole-genome sequencing of bone marrow aspirates in myelodysplastic neoplasms: A retrospective comparison with cytogenetics.
Rengifo LY; Smits S; Boeckx N; Michaux L; Vandenberghe P; Dewaele B
Genes Chromosomes Cancer; 2023 Nov; 62(11):663-671. PubMed ID: 37293982
[TBL] [Abstract][Full Text] [Related]
11. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.
Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA
Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608
[TBL] [Abstract][Full Text] [Related]
12. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
[TBL] [Abstract][Full Text] [Related]
13. Can genome array screening replace FISH as a front-line test in multiple myeloma?
Boneva T; Brazma D; Gancheva K; Howard-Reeves J; Raynov J; Grace C; Nacheva EP
Genes Chromosomes Cancer; 2014 Aug; 53(8):676-92. PubMed ID: 24757046
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.
Garcés JJ; Bretones G; Burgos L; Valdes-Mas R; Puig N; Cedena MT; Alignani D; Rodriguez I; Puente DÁ; Álvarez MG; Goicoechea I; Rodriguez S; Calasanz MJ; Agirre X; Flores-Montero J; Sanoja-Flores L; Rodriguez-Otero P; Rios R; Martinez-Lopez J; Millacoy P; Palomera L; Del Orbe R; Pérez-Montaña A; El Omri H; Prosper F; Mateos MV; Rosiñol L; Blade J; Lahuerta JJ; Orfao A; Lopez-Otin C; San Miguel JF; Paiva B;
Leukemia; 2020 Nov; 34(11):3007-3018. PubMed ID: 32475991
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing.
Chan KC; Jiang P; Chan CW; Sun K; Wong J; Hui EP; Chan SL; Chan WC; Hui DS; Ng SS; Chan HL; Wong CS; Ma BB; Chan AT; Lai PB; Sun H; Chiu RW; Lo YM
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18761-8. PubMed ID: 24191000
[TBL] [Abstract][Full Text] [Related]
16. Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.
Goldsmith SR; Fiala MA; Dukeman J; Ghobadi A; Stockerl-Goldstein K; Schroeder MA; Tomasson M; Wildes TM; Vij R
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):285-289. PubMed ID: 30792096
[TBL] [Abstract][Full Text] [Related]
17. Semiconductor Sequencing Analysis of Chromosomal Copy Number Variations in Spontaneous Miscarriage.
Wang MZ; Lin FQ; Li M; He D; Yu QH; Yang XX; Wu YS
Med Sci Monit; 2017 Nov; 23():5550-5557. PubMed ID: 29162795
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.
Smetana J; Frohlich J; Zaoralova R; Vallova V; Greslikova H; Kupska R; Nemec P; Mikulasova A; Almasi M; Pour L; Adam Z; Sandecka V; Zahradová L; Hajek R; Kuglik P
Biomed Res Int; 2014; 2014():209670. PubMed ID: 24987674
[TBL] [Abstract][Full Text] [Related]
19. Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
Sudha P; Ahsan A; Ashby C; Kausar T; Khera A; Kazeroun MH; Hsu CC; Wang L; Fitzsimons E; Salminen O; Blaney P; Czader M; Williams J; Abu Zaid MI; Ansari-Pour N; Yong KL; van Rhee F; Pierceall WE; Morgan GJ; Flynt E; Gooding S; Abonour R; Ramasamy K; Thakurta A; Walker BA
Clin Cancer Res; 2022 Jul; 28(13):2854-2864. PubMed ID: 35522533
[TBL] [Abstract][Full Text] [Related]
20. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]